CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma

BACKGROUND: Calmodulin1 (CALM1) has been identified as one of the overexpression genes in a variety of cancers and EGFR inhibitor have been widely used in clinical treatment but it is unknown whether CALM1 and epidermal growth factor receptor (EGFR) have a synergistic effect in esophageal squamous c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Cell Int
Autors principals: Liu, Tao, Han, Xiujuan, Zheng, Shutao, Liu, Qing, Tuerxun, Aerziguli, Zhang, Qiqi, Yang, Lifei, Lu, Xiaomei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890995/
https://ncbi.nlm.nih.gov/pubmed/33602237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01801-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars